Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07417241
What this trial is testing

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Peking University Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03979482
What this trial is testing

Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH

Who this might be right for
Pulmonary Artery Hypertension
Laval University 30
Not applicableNot Yet RecruitingNCT07685080
What this trial is testing

"Effectiveness of Supervised and Unsupervised mHealth-based Exercise Interventions on Clinical Outcomes in Adults With Type 2 Diabetes and Obesity Within a Primary Care Context"

Who this might be right for
Diabetes Mellitus, Type 2ObesityInsulin Resistance+5 more
Escuela Universitaria de Osuna 126
Testing effectiveness (Phase 2)Study completedNCT04437485
What this trial is testing

EIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Who this might be right for
DepressionMajor Depressive DisorderDysthymic Disorder+4 more
Indiana University 46
Large-scale testing (Phase 3)Ended earlyNCT05092360
What this trial is testing

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

Who this might be right for
Platinum-resistant Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Mural Oncology, Inc 456
Not applicableNot Yet RecruitingNCT07706335
What this trial is testing

Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.

Who this might be right for
STEMINo-Reflow PhenomenonDiabetic Patient
Assiut University 100
Not applicableUnknownNCT01163058
What this trial is testing

Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Istituto Clinico Humanitas 300
Large-scale testing (Phase 3)Study completedNCT00826774
What this trial is testing

Improving the Management of Obesity in Primary Care Practice (The Power-UP Trial)

Who this might be right for
ObesityHypercholesterolemiaMetabolic Syndrome+2 more
University of Pennsylvania 390
Not applicableStudy completedNCT04345198
What this trial is testing

Adrenal Artery Ablation for Primary Aldosteronism With Resistant Hypertension

Who this might be right for
Resistant Hypertension
Third Military Medical University 36
Testing effectiveness (Phase 2)Study completedNCT00993616
What this trial is testing

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+7 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Ended earlyNCT02379390
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
Sanofi 8
Early research (Phase 1)Ended earlyNCT06606327
What this trial is testing

Diazoxide Suppression Test P&F Study

Who this might be right for
Insulin ResistanceHyperinsulinemiaObesity
Columbia University 1
Testing effectiveness (Phase 2)Study completedNCT01613118
What this trial is testing

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Travere Therapeutics, Inc. 109
Testing effectiveness (Phase 2)Study completedNCT00004081
What this trial is testing

Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Beth Israel Deaconess Medical Center 30
Not applicableStudy completedNCT01759953
What this trial is testing

Educational Efficacy Assessment of a Serious Game to Teach Insulin Therapy to Primary Care Physicians

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Knowledge, Attitudes, Practice
Universidade Estadual de Londrina 170
Not applicableStudy completedNCT05168657
What this trial is testing

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Who this might be right for
Diabetes Mellitus, Type 1Type 1 DiabetesDiabetes, Autoimmune+11 more
University of Colorado, Denver 54
Not applicableLooking for participantsNCT05469373
What this trial is testing

ESIS in Pediatric DRE

Who this might be right for
Epilepsy
Sarah Katie Ihnen 86
Testing effectiveness (Phase 2)Study completedNCT01669798
What this trial is testing

BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
AA Secord 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07680322
What this trial is testing

The Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Aeovian Pharmaceuticals, Inc. 42
Next Page